Bristol-Myers Squibb Company was incorporated in Delaware in August 1933. It originated from a business founded in New York in 1887 and was renamed in 1989 due to the merger. As a biopharmaceutical company, Bristol-Myers Squibb focuses on the discovery, development, licensing, production, marketing and sales of innovative drugs to combat serious diseases. The Company's strategic approach combines the resources and scale of large pharmaceutical companies with the flexibility and innovation focus unique to the biotechnology industry. Bristol-Myers Squibb prioritizes transformative medicines in the fields of oncology, hematology, immunology, cardiovascular and neuroscience, aiming to provide long-term value and competitive advantage. As a global research pharmaceutical company, Bristol-Myers Squibb sells its products worldwide, serves a variety of entities including wholesalers, distributors and specialty pharmacy, and maintains important production operations in several countries.
